A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of decitabine (Dacogen)
intravenous injection in patients with Myelodysplastic Syndrome.